PGTai Results for Embryos Cultured in Sequential Versus Single Step Media
Sequential Versus Single Step Culture Media in Relation to Euploidy Rates in PGTai Program
1 other identifier
interventional
200
1 country
1
Brief Summary
A prospective cohort study undergoing ICSI at a private fertility center in Egypt
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 22, 2020
CompletedFirst Posted
Study publicly available on registry
July 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedJuly 24, 2020
June 1, 2020
1.2 years
July 22, 2020
July 22, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Euploidy rate
percentage of euploid embryos/ total genetic tested embryos on blast stage
5:7 days of intracytoplasmic sperm injection(ICSI)
Mosaicism rate
percentage of mosaic embryos/ total genetic tested embryos on blast stage
5:7 days of ICSI
Secondary Outcomes (5)
Fertilization rate
16:19 hours of ICSI
Cleavage stage
72 hours of ICSI
High quality of cleaved embryos
72 hours of ICSI
Blast formation rate
5:7 days of ICSI
High quality blast rate
5:7 days of ICSI
Study Arms (2)
Single step media
ACTIVE COMPARATOREmbryos cultured in single step media
Sequential media
ACTIVE COMPARATOREmbryos cultured in sequential media
Interventions
Eligibility Criteria
You may qualify if:
- Female age ≤37 years with ≥ 8 mature oocytes
- Male partner had normal semen parameters according to WHO 2010
- PGT-A was done at the blastocyst stage
You may not qualify if:
- sperm or oocyte donor
- severe male factors according to WHO 2010
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ganin Fertility Center
Cairo, 11728, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manar M Hozyen, MSc.
Ganin Fertility Center
- PRINCIPAL INVESTIGATOR
Amr Elshimy, BSc.
Ganin Fertility Center
- PRINCIPAL INVESTIGATOR
Hanaa Elkhader, BSc.
Ganin Fertility Center
- STUDY CHAIR
Hosam Zaki, MSc.
Ganin Fertility Center
Central Study Contacts
Amr Elshimy, BSc.
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 22, 2020
First Posted
July 24, 2020
Study Start
December 1, 2019
Primary Completion
March 1, 2021
Study Completion
June 1, 2021
Last Updated
July 24, 2020
Record last verified: 2020-06